home / stock / nvo / nvo news


NVO News and Press, Novo Nordisk A/S From 06/06/24

Stock Information

Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE

Menu

NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...

NVO - Ozempic Just Got Even More Bullish For Novo Nordisk Stock, Yet Again

2024-06-06 07:00:00 ET The medicine for type 2 diabetes called Ozempic is, without a doubt, Novo Nordisk 's (NYSE: NVO) knight in shining armor. Thanks to an impressive amount of demand and the company's dedicated efforts in exploring other conditions that the medicine could potenti...

NVO - LifeMD gains as KeyBanc issues bullish view on weight loss program

2024-06-05 13:44:31 ET More on LifeMD LifeMD: Moving Towards Profitability LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript LifeMD, Inc. 2024 Q1 - Results - Earnings Call Presentation LifeMD Q1 2024 Earnings Preview LifeMD Non-GAAP EPS of $0.15 be...

NVO - US Companies Moving the Markets, Evening edition
Tue, Jun 04, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 74.6% to $0.46 on volume of 265,324,361 shares MicroAlgo Inc. (MLGO) rose 669.9% to $12.01 on volume of 183,977,846 shares PROSHARES TRUST (SQQQ) fell 0.7% to $9.86 on volume of 124,114,596 shares Faraday ...

NVO - Eli Lilly wins favorable terms for obesity drug use in U.K.

2024-06-04 14:57:26 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Novo Nordisk: The Market Is Right, Don't Fight Against It Eli Lilly sees...

NVO - Waistlines And GLP1s - Expanding In Unison

2024-06-04 13:50:00 ET Summary More than 800 million people are estimated to be overweight or obese worldwide, and the growing prevalence of obesity, despite the availability of various treatments, suggests that isn’t going to change. The potential $500 billion market for G...

NVO - Here Are 3 More Reasons to Be Bullish on Ozempic and Novo Nordisk Stock

2024-06-04 09:53:00 ET Novo Nordisk 's (NYSE: NVO) type 2 diabetes drug Ozempic is a sensation, and it's no surprise why. In the first quarter, revenue from Ozempic rose 35% year over year to reach roughly $4.3 billion, and there's no sign of a slowdown in sight. In fact, it's v...

NVO - Tracking George Soros's 13F Portfolio - Q1 2024 Update

2024-06-03 20:03:51 ET Summary Soros Fund Management's 13F portfolio value decreased from $7.65B to $6.02B in Q1 2024. New stakes include Cloudflare Inc. Puts, Cerevel Therapeutics, and Aramark. Stake disposals include Apple Puts, PDD Holdings Puts, and SPDR Index Euro Stocks ...

NVO - Novo Nordisk launches national Wegovy® campaign, Power of Wegovy®

Novo Nordisk launches national Wegovy® campaign, Power of Wegovy® PR Newswire Designed to celebrate diverse, unique portrayals of individuals who partner with their healthcare professional to change the course of their weight-management journey, while educating on ...

NVO - Earn An 'Embarrassing' Amount Of Cash Flow From These Contrarian Picks

2024-06-03 08:10:00 ET Summary Amazon CEO Andy Jassy highlights key traits for success in a career professional, including working hard, being can-do, and following through on commitments. There are different paths to success, and income investors can potentially achieve a high le...

NVO - SA Asks: Which weight-loss stocks should investors be watching?

2024-06-02 10:00:00 ET More on Amgen, Structure Therapeutics, etc. Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe? ...

Previous 10 Next 10